Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity

Published:2018-05-17 Issue:10 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Wang Dongrui,Aguilar Brenda^ORCID,Starr Renate,Alizadeh Darya,Brito Alfonso,Sarkissian Aniee,Ostberg Julie R.,Forman Stephen J.,Brown Christine E.

Funder

California Institute for Regenerative Medicine

National Cancer Institute

U.S. Food and Drug Administration

Gateway for Cancer Research

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/99048/files/pdf

Reference73 articles.

1. Smart CARs engineered for cancer immunotherapy

2. The Basic Principles of Chimeric Antigen Receptor Design

3. Engineered T cells: the promise and challenges of cancer immunotherapy

4. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

5. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy;Bioengineering & Translational Medicine;2024-08-31

2. B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibiting tumor infiltrating CD4+T cell cytotoxicity through ESM1;npj Precision Oncology;2024-07-01

3. Vaccine-based immunotherapy and related preclinical models for glioma;Trends in Molecular Medicine;2024-07

4. Optimization of In Vitro Th17 Polarization for Adoptive Cell Therapy in Chronic Lymphocytic Leukemia;International Journal of Molecular Sciences;2024-06-07

5. Pharmacodynamic changes in tumor and immune cells drive iberdomide’s clinical mechanisms of activity in relapsed and refractory multiple myeloma;Cell Reports Medicine;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3